CClinicalTrials.gg
CompletedNCT02668250OPTI-AGEDUpdated Aug 26, 2021

Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality

An interventional study of OPTI-AGED and Usual Care in Coronary; Ischemic, Arrhythmias, Cardiac and Heart Failure, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Completed at 29 sites in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2021-08-26.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
2,495
Allocation
Randomized
Ages
75 Years and older
Sex
All
01

Study summary

With the increasing aging population demographics and life expectancies, the number of very elderly patients undergoing surgery is rising. Elderly patients constitute an increasingly large proportion of the high-risk surgical group.

Cardiac complications and postoperative pulmonary complications are equally prevalent and contribute similarly to morbidity, mortality, and length of hospital stay. Specific optimization strategy of general anesthesia has been tested in high-risk patients undergoing major surgery to improve outcomes.

Our hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly undergoing high risk surgery.

Read the detailed description

The population is expanding and aging. With the increasing aging population demographics and life expectancies, the number of very elderly patients (age ≥ 75) undergoing surgery is rising. Elderly patients constitute an increasingly large proportion of the high-risk surgical group. In 2010, patients aged 75 yrs and over represented only 2.1% of patients undergoing high risk surgery in France (PMSI database), but concentrated 27% of in-hospital deaths.

Cardiac complications and postoperative pulmonary complications are equally prevalent and contribute similarly to morbidity, mortality, and length of hospital stay. Specific optimization strategy of general anesthesia has been tested in high-risk patients undergoing major surgery to improve outcomes. Meta-analyses have demonstrated that goal directed hemodynamic therapy significantly reduced mortality and surgical complications in high-risk patients. A lung-protective ventilation strategy in high-risk patients undergoing major abdominal surgery was associated with improved clinical outcome. Retrospective studies indicated that a combination of excessive depth of anesthesia, hypotension and low anesthesia requirement resulted in increased mortality. These approaches of peroperative care remain discussed in the literature and have also to be incorporated in the common clinical practice. Moreover, few of these reviews performed a sensitive analysis in the elderly.

Whether a multi-parametric optimization strategy of anesthesia including several specific interventions will impact the short-term postoperative major morbidity and mortality in elderly is not known. The addition of depth of anesthesia monitoring to hemodynamic monitoring and goal directed hemodynamic therapy may improve tissue perfusion by reducing hemodynamic side effects of anesthetic agents, particularly in elderly where the therapeutic window of these agents is reduced. The effects of low protective ventilation may also by additive to the previous measures by reducing the perioperative build-up of oxygen debt. Our hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly undergoing high risk surgery.

02

Conditions studied

  • Coronary; Ischemic
  • Arrhythmias, Cardiac
  • Heart Failure
  • Peripheral Vascular Diseases
  • Dementia
  • Stroke
  • Pulmonary Disease, Chronic Obstructive
  • Respiratory Insufficiency
  • Alcoholism
  • Cancer
  • Diabetes
  • Renal Insufficiency
03

In context

Pulmonary Disease, Chronic Obstructive

4,131 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 697 are open to participants now.

This study's enrollment of 2,495 is above the median of 70 across 2,926 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 578 studies on the registry; 128 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All adult patients aged 75 years and over,
  • presenting at least one of the following comorbidities: ischemic coronary disease; cardiac arrhythmia; congestive heart failure; peripheral vascular disease; dementia; stroke; chronic obstructive pulmonary disease; chronic respiratory failure; chronic alcohol abuse; active cancer; diabetes; chronic renal failure A comorbidity index will be measured by using the modified Charlson Comorbidity Index
  • undergoing elective and emergency surgeries including : femoral head fracture, major intraperitoneal abdominal surgery lasting > 90 min (excluding elective cholecystectomy, abdominal wall surgery), vascular surgery (excluding venous surgery and fistula creation)
  • Patient's or patient's relative signed consent form
  • Affiliation to French social assurance system

Exclusion criteria

Exclusion Criteria:

  • Acute heart failure and acute coronary syndrome
  • Acute respiratory failure, pneumonia
  • Septic shock
  • Delirium
  • Acute stroke
  • Evolutive neuromuscular disorder
  • Thoracic surgery, combined abdominal and thoracic surgery
  • Surgery performed under exclusive regional anesthesia
  • Patients under tutorship or curatorship
  • Refusal to participate
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,495 participants (actual)

Study arms

  • Experimental
    Experimental group : OPTI-AGED

    The OPTI-AGED group will receive a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia.

    Procedure: OPTI-AGED

  • Active comparator
    Control Group :

    The control group will not benefit from the OPTI-AGED intervention but patients will receive the usual care.

    Procedure: Usual Care

Interventions

  • ProcedureOPTI-AGED

    OPTI-AGED is composed of a multi-parametric optimization strategy.

  • ProcedureUsual Care

    Patients receive the usual care.

06

What researchers measure

Primary outcomes

  1. Incidence of a composite of mortality or major postoperative morbidity.

    One or more of major postoperative complications : acute kidney injury (defined by Kidney disease : improving Global Outcomes (KDIGO) stage 1 or higher), acute myocardial infarction, heart failure, stroke, development of sepsisand septic shock, acute respiratory failure requiring non-invasive ventilation or intubation, delirium) will be reported in the source folder of the patients, and the mortality will be also focused. The goal of this study is to decrease this incidence.

    Time frame: Day 30

07

Study locations

29 sites
  • CHU Amiens - Picardie
    Amiens, France
  • CHU CAEN
    Caen, France
  • Chu Clermont-Ferrand
    Clermont-Ferrand, 63003, France
  • Chu Dijon
    Dijon, 21079, France
  • Médipôle Lyon - Villeurbanne
    Décines-Charpieu, France
  • Chu Grenoble
    Grenoble 9, 38043, France
  • CHRU Lille - Salengro
    Lille, 59000, France
  • CHU LILLE - Huriez
    Lille, 59037, France
  • CHU LYON
    Lyon, France
  • Lyon Sud - CHU
    Lyon, France
  • Chu Marseille La Timone
    Marseille, 13385, France
  • Chu Marseille Nord
    Marseille, 13385, France
  • Chu Montpellier
    Montpellier 5, 34295, France
  • Chu Nancy
    Nancy, 54035, France
  • CHU de Nantes
    Nantes, France
  • CHU NICE
    Nice, France
  • Chu Nimes
    Nîmes, France
  • Ch Paris Beaujon
    Paris, France
  • Ch Paris Bichat
    Paris, France
  • Ch Paris Pitie Salpetriere
    Paris, France
  • Ch Paris Saint Antoine
    Paris, France
  • Ch Saint Louis-Lariboisiere
    Paris, France
  • Chu Poitiers
    Poitiers, 86021, France
  • Chu Rennes
    Rennes, France
  • Chu Rouen
    Rouen, 76031, France
  • Chu Saint Etienne
    Saint Etienne, 42100, France
  • Hopital Central Strasbourg
    Strasbourg, 67098, France
  • Hopital Hautepierre Strasbourg
    Strasbourg, 67098, France
  • Chu Toulouse
    Toulouse 9, 31059, France
08

References and documents

Publications

  • Molliex S, Passot S, Futier E, Bonnefoi M, Rancon F, Lemanach Y, Pereira B. Stepped wedge cluster randomised controlled trial to assess the effectiveness of an optimisation strategy for general anaesthesia on postoperative morbidity and mortality in elderly patients (the OPTI-AGED study): a study protocol. BMJ Open. 2018 Jun 19;8(6):e021053. doi: 10.1136/bmjopen-2017-021053. PubMed 29921685 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02668250
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Ministry of Health, France
Responsible party
Sponsor
First posted
Jan 29, 2016
Start date
Feb 3, 2017
Primary completion
Feb 5, 2020
Completion
Mar 16, 2021
Last update
Aug 26, 2021

Study contacts

MOLLIEX Serge, MD
principal investigator · CHU SAINT ETIENNE

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion